• About us
• Contact

Advertisement

Product › Details

crenezumab

	Next higher product group	Alzheimer drug
	Status	2014-12-19 development p2 existent
	Status	2019-01-30 development end–negat
	Organisation	Roche (Group)

Record changed: 2023-07-10

Advertisement

More documents for Alzheimer drug

• [1] BioArctic AB. (8/22/24). "Press Release: Leqembi (lecanemab) Authorized for Early Alzheimer’s Disease in Great Britain". Stockholm....
• [2] Asceneuron S.A.. (7/16/24). "Press Release: Asceneuron Secures $100 Million Series C Financing to Advance Groundbreaking Therapeutics in Neurodegenerative Diseases". Lausanne & San Francisco, CA....
• [3] AC Immune S.A.. (5/13/24). "Press Release: AC Immune and Takeda Sign Exclusive Option and License Agreement for Active Immunotherapy Targeting Amyloid Beta for Alzheimer’s Disease". Osaka, Cambride, MA & Lausanne....
• [4] Roche. (4/11/24). "Press Release: Roche Granted FDA Breakthrough Device Designation for Blood Test to Support Earlier Alzheimer's Disease Diagnosis". Basel....
• [5] AstronauTx Ltd.. (10/9/23). "Press Release: AstronauTx Closes £48 Million ($61 Million) Series A Financing to Create New Treatments for Alzheimer’s Disease". London....
• [6] Asceneuron S.A.. (10/6/23). "Press Release: Asceneuron Welcomes Barbara Angehrn Pavik as New CEO as It Gears Up for Next Phase of Growth". Lausanne....
• [7] Saniona AB. (7/17/23). "Press Release: Saniona Enters into Collaboration Agreement with AstronauTx in Alzheimer’s Disease"....
• [8] AC Immune S.A.. (6/27/23). "Press Release: AC Immune Receives FDA Fast Track Designation for Anti-Amyloid-beta Active Immunotherapy, ACI-24.060, to Treat Alzheimer’s Disease". Lausanne....
• [9] Roche. (3/22/23). "Press Release: Roche Announces Collaboration with Lilly to Enhance Early Diagnosis of Alzheimer's Disease". Basel....
• [10] Alzinova AB. (1/24/23). "Press Release: Alzinova Recruits Business Development Director"....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to [email protected] and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Advertisement

» top

» Imprint  |  » Data Privacy  |  » Contact  |  The use of this website requires to accept the » Disclaimer!   |  A project of [iito] Business Intelligence © 2002-2024. Made in Germany.